PUK12 A COST-UTILITY ANALYSIS OF SOLIFENACIN 5 MG AND 10 MGVERSUS FESOTERODINE 4 MG AND 8 MG IN THE PHARMACOLOGICAL TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER (OAB) IN THE UK NHS

✍ Scribed by L Cardozo; A Thorpe; M Grishchenko; MK Sidhu

• Book ID: 118607399
• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 69 KB
• Volume: 11
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)67126-4